Post-earnings recap
Reported
Thu, Apr 30, 2026
EPS actual
$0.05
EPS est.
$0.01
EPS surprise
+400.00%
1-day move
+3.78%
Alignment Healthcare reported an EPS that beat expectations, although revenue figures were not disclosed. The stock reacted positively, rising by 3.78%. Investors may view the EPS surprise as a sign of better-than-expected profitability, despite the lack of revenue data and management commentary.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.05 | $0.09 | +400.00% |
| Revenue | N/A | $1.2B | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Alignment Healthcare, Inc. (ALHC) operates in the health care sector, focusing on managed health care services. The company aims to improve patient outcomes while controlling costs, which is increasingly important as healthcare demands grow and costs rise.
Last quarter
In Q4-2025, Alignment Healthcare reported an EPS of -$0.05, outperforming expectations of -$0.15. The stock reacted positively, gaining 1.44% the following day.
Management promises and guidance
EPS beat streak
7Q
EPS beat rate
88%
Avg EPS surprise
+112.77%
Avg 1-day reaction
+1.23%
Analysts expect a modest earnings performance this quarter, with a consensus EPS of $0.09 and revenue of $1.2 billion. The market is closely watching how well the company can maintain its growth trajectory.
Bull case
If Alignment Healthcare beats EPS estimates and shows strong revenue growth, it could signal robust demand for its services and lead to a positive revaluation of the stock.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its ability to compete in a challenging health care environment.
Key metrics to watch
EPS
$0.09Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating revenue.
Revenue
$1.2BTotal revenue is crucial for understanding the company's growth and market position in the managed health care industry.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $0.09?
A strong EPS performance could indicate effective cost management and operational efficiency, which investors are keen to see.
Q2
How does the company plan to achieve its revenue target of $1.2 billion?
Understanding the growth strategy and market dynamics will be crucial for assessing future performance and investor confidence.
—
Est. EPS
$2.40
Est. Rev
$3.3B
Impl. Move
±19.0%
Why consensus could be wrong
The Street may be underestimating the potential for Alignment Healthcare to exceed revenue expectations due to recent operational improvements and market expansion efforts.
Supporting evidence
The company has a strong track record of beating EPS estimates, with a 75% success rate over the last eight quarters.
Recent insider selling could indicate confidence in the company's long-term strategy despite short-term fluctuations.
Key risk
If the company reports revenue significantly above $1.2 billion, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's results will be pivotal in determining whether Alignment Healthcare can sustain its growth and profitability in a competitive market.
Bull confirmed if
Achieving an EPS of $0.10 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $0.07 would raise concerns about the company's growth prospects and operational challenges.
What the market is pricing for the move.
Implied Move
±10.64%
Historical Avg
±4.1%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±10.6% while ALHC has averaged ±4.1% over the last 8 prints — setup is pricing rich.
ATM IV
0.7%
30d HV
54.7%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$0.00
0 sh
0 insiders
Sold
$13.7M
1,066,967 sh
4 insiders
Net
$13.7M
Net selling
Most Active Insiders· 8 open-market trades
$11.6M
Net selling
Smart-money positioning from the most recent 13F filings.
Institutional
115.99%
of float
Insider
2.57%
of float
Holders
435
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
19,342,956 sh · $165.4M
9.32%
37.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If the company beats estimates, history suggests a potential stock increase of around 0.24%, confirming positive momentum.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with historical data indicating an average drop of around 1.12% following earnings misses.
The lines on the call that would change the story.
$1.6M
Net selling
$269,575.70
Net selling
$202,429.71
Net selling
Recent Transactions
Sep 11, 2026 · @ $12.68
385,270 sh
$4.9M
Aug 10, 2026 · @ $13.88
298,000 sh
$4.1M
Sep 10, 2026 · @ $12.96
172,600 sh
$2.2M
Sep 11, 2026 · @ $12.68
122,707 sh
$1.6M
Sep 14, 2026 · @ $13.00
27,400 sh
$356,200.00
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.
Wellington Management Group, LLP
18,780,363 sh · $160.6M
9.05%
9.8%
FMR, LLC
13,924,329 sh · $119.1M
6.71%
-12.4%
T. Rowe Price Investment Management, Inc.
13,119,557 sh · $112.2M
6.32%
-0.2%
Vanguard Portfolio Management LLC
11,672,259 sh · $99.8M
5.63%
20.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.